Literature DB >> 17303988

Clinical assessment of the DINAMAP ProCare monitor in an adult population according to the British Hypertension Society Protocol.

Annemarie de Greeff1, Fayrouge Reggiori, Andrew H Shennan.   

Abstract

OBJECTIVE: Clinical recommendation of an automated blood pressure device is dependent on assessment according to a recognized protocol. The DINAMAP ProCare monitor is an oscillometric device intended for hospital, physician office or clinic use. The device algorithm was developed and tested against an auscultatory standard to increase comparability, in contrast to previous DINAMAP products that were designed to be accurate compared with an invasive central aortic reference, as specified in the Association for the Advancement of Medical Instrumentation-SP10 Standard (AAMI SP10 Standard: 1992, 2002). This device was validated in an adult population according to the protocol of the British Hypertension Society.
METHODS: Local ethics committee approval was obtained and all patients were required to give written informed consent. Nine sequential same-arm measurements, alternating between observer and device, were taken from each patient. Data analysis was performed according to the guidelines of the British Hypertension Society protocol on 85 patients who fulfilled the blood pressure categories specified by the protocol.
RESULTS: The DINAMAP ProCare monitor achieved an A grade for both systolic and diastolic pressures. It also achieved the passing criteria of the ANSI/AAMI SP10 with a mean difference (standard deviation) for systolic and diastolic pressures, respectively, of -0.3 (6.9) and -4.0 (5.9) mmHg.
CONCLUSION: The DINAMAP ProCare monitor can be recommended for clinical use in an adult population according to the criteria of the British Hypertension Society.

Entities:  

Mesh:

Year:  2007        PMID: 17303988     DOI: 10.1097/MBP.0b013e3280858b73

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  13 in total

1.  Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.

Authors:  James P Corsetti; Ron T Gansevoort; Stephan J L Bakker; Charles E Sparks; Priya Vart; Robin P F Dullaart
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

2.  Validation of Datascope Accutorr Plus™ using British Hypertension Society (BHS) and Association for the Advancement of Medical Instrumentation (AAMI) protocol guidelines.

Authors:  Rajab Ali Khawaja; Riaz Qureshi; Abdul Hay Mansure; Mohammad Emran Yahya
Journal:  J Saudi Heart Assoc       Date:  2010-03-10

3.  Cardiovascular disease risk factor clustering among African American adults.

Authors:  Meghan Baruth; Sara Wilcox; Brent M Egan; Marsha Dowda; Marilyn Laken; Tatiana Y Warren
Journal:  Ethn Dis       Date:  2011       Impact factor: 1.847

4.  Decades after the cooperative study: a re-examination of systemic blood pressure in sickle cell disease.

Authors:  Payal C Desai; Allison M Deal; Julia E Brittain; Susan Jones; Alan Hinderliter; Kenneth I Ataga
Journal:  Am J Hematol       Date:  2012-06-20       Impact factor: 10.047

Review 5.  Determining which automatic digital blood pressure device performs adequately: a systematic review.

Authors:  Y Wan; C Heneghan; R Stevens; R J McManus; A Ward; R Perera; M Thompson; L Tarassenko; D Mant
Journal:  J Hum Hypertens       Date:  2010-04-08       Impact factor: 3.012

6.  Predictors of change in fruit and vegetable consumption in a faith-based intervention with African American adults.

Authors:  Margaret D Condrasky; Meghan Baruth; Sara Wilcox; Chad Carter
Journal:  Fam Community Health       Date:  2013 Jul-Sep

7.  The Faith, Activity, and Nutrition program: a randomized controlled trial in African-American churches.

Authors:  Sara Wilcox; Allen Parrott; Meghan Baruth; Marilyn Laken; Margaret Condrasky; Ruth Saunders; Marsha Dowda; Rebecca Evans; Cheryl Addy; Tatiana Y Warren; Deborah Kinnard; Lakisha Zimmerman
Journal:  Am J Prev Med       Date:  2013-02       Impact factor: 5.043

8.  Agreement of blood pressure measurements between random-zero and standard mercury sphygmomanometers.

Authors:  Wenjie Yang; Dongfeng Gu; Jing Chen; Cashell E Jaquish; D C Rao; Xigui Wu; James E Hixson; Xiufang Duan; Tanika N Kelly; L Lee Hamm; Paul K Whelton; Jiang He
Journal:  Am J Med Sci       Date:  2008-11       Impact factor: 2.378

9.  Agreement between blood pressure from research study visits versus electronic medical records and associations with hypertensive disorder diagnoses in pregnant women with overweight/obesity.

Authors:  Abbi D Lane-Cordova; Sara Wilcox; Bo Fernhall; Jihong Liu
Journal:  Blood Press Monit       Date:  2021-10-01       Impact factor: 1.430

10.  Assessing cardiovascular risk in regional areas: the Healthy Hearts Beyond City Limits program.

Authors:  Melinda J Carrington; Garry L Jennings; Robyn A Clark; Simon Stewart
Journal:  BMC Health Serv Res       Date:  2012-09-03       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.